Results 331 to 340 of about 93,200 (346)

Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial

Lancet, The, 2020
Atul Deodhar, Mrcp, Wolf-Henning Boehncke, Christopher T Ritchlin   +2 more
exaly  

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021

Nature Reviews Rheumatology, 2022
Laura C Coates Mb Chb, Nadia Corp, Kristina Callis Duffin   +2 more
exaly  

Psoriatic arthritis editorial

Musculoskeletal Care, 2022
openaire   +2 more sources

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

Lancet, The, 2000
Philip J Mease
exaly  

Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial

Lancet, The, 2020
Iain B Mcinnes, Frank Behrens, Philip J Mease   +2 more
exaly  

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2015
Iain B Mcinnes, Philip J Mease, Bruce W Kirkham   +2 more
exaly  

Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial

Lancet, The, 2015
Laura C Coates Mb Chb, David M Meads, Paul Emery   +2 more
exaly  

Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial

Lancet, The, 2020
Arthur Kavanaugh, Joseph F Merola, Georg Schett   +2 more
exaly  

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial

Lancet, The, 2009
Alan Menter, Arthur Kavanaugh
exaly  

Psoriatic Arthritis

Clinics in Rheumatic Diseases, 1985
openaire   +2 more sources